Arcus Biosciences Inc (RCUS) — Cash Flow Quality Index
Arcus Biosciences Inc (RCUS) has a Cash Flow Quality Index of -0.22x as of December 2021. Operating cash flow of $-62.10 Million is below net income of $279.37 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore RCUS cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Arcus Biosciences Inc Cash Flow Quality Index (2021–2021)
Historical Cash Flow Quality Index for Arcus Biosciences Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check RCUS total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Arcus Biosciences Inc (2021–2021)
Year-by-year earnings quality comparison for Arcus Biosciences Inc. For live market cap and the full company financial profile, see RCUS market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -4.85x | $-256.17 Million | $52.83 Million | — |